Vivelle-Dot, a tiny new estrogen patch

June 1999

You'll soon see Vivelle-Dot, a tiny new estrogen patch. It's about the size of a postage stamp.

Vivelle-Dot is approved for treating menopausal symptoms.

It comes in the same strengths as the original Vivelle patch...0.0375, 0.05, 0.075 and 0.1 mg/day.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

new med for type 2 diabetes, Avandia (rosiglitazone)
Neurology & Pain withdrawal symptoms after stopping an antidepressant
Neurology & Pain whether Aricept (donepezil) or vitamin E can PREVENT or delay Alzheimer's
Vioxx (rofecoxib), a new COX-2 inhibitor
possible interaction between Celebrex and warfarin
possible risk of serious infection with the new rheumatoid arthritis drug, Enbrel (etanercept)
MSM, a new supplement that's being widely promoted for pain and arthritis
Dermatology Nizoral A-D, the first OTC ketoconazole shampoo for dandruff
Pediatrics prescribe Amoxil BID for children
Pediatrics large increase in clonidine poisonings in children
Pediatrics new conjugated pneumococcal vaccine that's being tested for INFANTS
Cardiology more aggressive treatment of dyslipidemia to prevent heart disease in WOMEN
Cardiology two new margarines that actually help LOWER cholesterol
DRUG therapy to help patients reduce or stop drinking
Women's Health Vivelle-Dot, a tiny new estrogen patch
Women's Health single-dose fluconazole during early pregnancy isn't likely to cause birth defects
Infectious Diseases Hepatitis C Check, the first home test kit for hepatitis C
Infectious Diseases some HIV patients can STOP taking drugs to prevent two opportunistic infections
Pharmacogenetics hear a lot about pharmacogenetics